Hirotoshi Yasui, Ryo Fukaura, Miyu Misaki, Souma Usui, Saho Katsumata, Ryo Niimi et al. Probable Stevens–Johnson Syndrome During Taletrectinib Treatment After Crizotinib‐Related Rash in ROS1‐Positive Lung Cancer. // Respirology Case Reports. – 2026. – DOI: 10.1002/rcr2.70782. – URL: https://onlinelibrary.wiley.com/doi/10.1002/rcr2.70782?af=R
Hirotoshi Yasui, Ryo Fukaura, Miyu Misaki, Souma Usui, Saho Katsumata, Ryo Niimi, Ko Ohara, Kaito Sano, Yasutaka Mori, Tomofumi Shibata, Yasutaka Fukui, Mitsuru Odate, & Yasushi Makino (2026). Probable Stevens–Johnson Syndrome During Taletrectinib Treatment After Crizotinib‐Related Rash in ROS1‐Positive Lung Cancer. Respirology Case Reports. https://doi.org/10.1002/rcr2.70782
Hirotoshi Yasui, et al. “Probable Stevens–Johnson Syndrome During Taletrectinib Treatment After Crizotinib‐Related Rash in ROS1‐Positive Lung Cancer.” Respirology Case Reports, 2026. doi:10.1002/rcr2.70782.
@article{Yasui2026,
title = {Probable Stevens–Johnson Syndrome During Taletrectinib Treatment After Crizotinib‐Related Rash in ROS1‐Positive Lung Cancer},
author = {Yasui, Hirotoshi and Fukaura, Ryo and Misaki, Miyu and Usui, Souma and Katsumata, Saho and Niimi, Ryo and Ohara, Ko and Sano, Kaito and Mori, Yasutaka and Shibata, Tomofumi and Fukui, Yasutaka and Odate, Mitsuru and Makino, Yasushi},
journal = {Respirology Case Reports},
year = {2026},
doi = {10.1002/rcr2.70782},
url = {https://onlinelibrary.wiley.com/doi/10.1002/rcr2.70782?af=R}
}